| P2093 | author name string | N Aggarwal | |
| | S J Cox | |
| | P V Barnett | |
| | R J Statham | |
| P2860 | cites work | Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. | Q45868911 |
| | Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. | Q64931553 |
| | The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8 | Q69522304 |
| | Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccines | Q71791667 |
| | Antibody response of pigs to foot-and-mouth disease oil emulsion vaccine: the antibody classes involved | Q72938030 |
| | Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission | Q74486559 |
| | Innate immunity: the virtues of a nonclonal system of recognition | Q29614428 |
| | International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants | Q33464056 |
| | Optimisation of the immune response to foot-and-mouth disease vaccines | Q33589235 |
| | Interleukin-8 and the chemokine family. | Q34303829 |
| | A review of emergency foot-and-mouth disease (FMD) vaccines | Q34540795 |
| | Developments in foot-and-mouth disease vaccines | Q36395476 |
| | Antibody response to viral antigens. | Q39938393 |
| | Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. | Q41345772 |
| | Adjuvants--a classification and review of their modes of action | Q41461373 |
| | Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state | Q42064405 |
| | Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle | Q42128756 |
| | Relative resistance of pigs to infection by natural aerosols of FMD virus | Q44319197 |
| | Growth of foot-and mouth disease virus in monolayer cultures of calf thyroid cells | Q44399792 |
| | Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission | Q45202555 |
| | Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs | Q45732599 |
| | Natural aerosol transmission of foot-and-mouth disease virus to pigs: minimal infectious dose for strain O1 Lausanne | Q45732600 |
| | Foot-and-mouth disease in swine. I. The immune response of swine of chemically-treated and non-treated foot-and-mouth disease virus | Q45823730 |
| | Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus | Q45851273 |
| P433 | issue | 13-14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 1336-1347 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines | |
| P478 | volume | 21 | |